Latest Insider Transactions at Enzo Biochem Inc (ENZ)
This section provides a real-time view of insider transactions for Enzo Biochem Inc (ENZ). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ENZO BIOCHEM INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ENZO BIOCHEM INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 16
2025
|
Bradley Louis Radoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
142,897
+3.06%
|
-
|
|
Jan 16
2025
|
Jonathan Couchman Director |
BUY
Grant, award, or other acquisition
|
Direct |
142,897
+50.0%
|
-
|
|
Jan 16
2025
|
Steven J Pully Director |
BUY
Grant, award, or other acquisition
|
Direct |
142,897
+37.32%
|
-
|
|
Jul 24
2024
|
Kara Cannon Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
70,885
-15.71%
|
$70,885
$1.17 P/Share
|
|
Feb 23
2024
|
Kara Cannon Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+24.95%
|
-
|
|
Feb 21
2024
|
Kara Cannon Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,823
-1.9%
|
-
|
|
Feb 21
2024
|
Kara Cannon Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,640
+3.35%
|
-
|
|
Jan 31
2024
|
Bradley Louis Radoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
79,365
+1.78%
|
-
|
|
Jan 31
2024
|
Mary Tagliaferri Director |
BUY
Grant, award, or other acquisition
|
Direct |
79,365
+20.26%
|
-
|
|
Jan 31
2024
|
Steven J Pully Director |
BUY
Grant, award, or other acquisition
|
Direct |
79,365
+44.98%
|
-
|
|
Oct 30
2023
|
Steven J Pully Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,730
+50.0%
|
-
|
|
Aug 31
2023
|
Kara Cannon Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
63,700
-17.69%
|
$63,700
$1.54 P/Share
|
|
Aug 31
2023
|
Kara Cannon Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
345,080
+48.93%
|
-
|
|
Feb 13
2023
|
Ian B. Walters Director |
BUY
Grant, award, or other acquisition
|
Direct |
75,188
+32.53%
|
-
|
|
Feb 13
2023
|
James G. Wolf |
BUY
Open market or private purchase
|
Indirect |
5,000
+4.17%
|
$5,000
$1.29 P/Share
|
|
Feb 13
2023
|
James G. Wolf |
BUY
Open market or private purchase
|
Direct |
5,000
+0.12%
|
$5,000
$1.28 P/Share
|
|
Feb 10
2023
|
James G. Wolf |
BUY
Open market or private purchase
|
Direct |
5,000
+0.12%
|
$5,000
$1.29 P/Share
|
|
Feb 09
2023
|
Bradley Louis Radoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
75,188
+1.71%
|
-
|
|
Feb 09
2023
|
Mary Tagliaferri Director |
BUY
Grant, award, or other acquisition
|
Direct |
75,188
+32.53%
|
-
|
|
Jan 27
2023
|
James G. Wolf |
BUY
Open market or private purchase
|
Direct |
11,800
+0.29%
|
$11,800
$1.4 P/Share
|
|
Jan 23
2023
|
James G. Wolf |
BUY
Conversion of derivative security
|
Direct |
263,200
+3.1%
|
$789,600
$3.75 P/Share
|
|
Dec 28
2022
|
Kara Cannon Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,600
+45.49%
|
-
|
|
Dec 16
2022
|
James G. Wolf |
BUY
Conversion of derivative security
|
Direct |
33,700
+0.88%
|
$67,400
$2.5 P/Share
|
|
Dec 15
2022
|
James G. Wolf |
BUY
Conversion of derivative security
|
Direct |
85,100
+2.2%
|
$170,200
$2.5 P/Share
|
|
Dec 14
2022
|
James G. Wolf |
BUY
Conversion of derivative security
|
Direct |
136,200
+3.55%
|
$272,400
$2.5 P/Share
|
|
Nov 23
2022
|
Hamid Erfanian Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
100,000
+21.07%
|
$100,000
$1.97 P/Share
|
|
Nov 21
2022
|
James G. Wolf |
BUY
Conversion of derivative security
|
Direct |
24,700
+0.69%
|
$49,400
$2.5 P/Share
|
|
Nov 17
2022
|
James G. Wolf |
BUY
Conversion of derivative security
|
Direct |
300
+0.01%
|
$600
$2.5 P/Share
|
|
Nov 01
2022
|
James G. Wolf |
BUY
Open market or private purchase
|
Indirect |
8,500
+1.03%
|
$17,000
$2.15 P/Share
|
|
Oct 31
2022
|
James G. Wolf |
BUY
Open market or private purchase
|
Indirect |
14,500
+3.38%
|
$29,000
$2.15 P/Share
|
|
Jul 15
2022
|
Kara Cannon Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+50.0%
|
$5,000
$2.42 P/Share
|
|
Jul 12
2022
|
Mary Tagliaferri Director |
BUY
Grant, award, or other acquisition
|
Direct |
41,666
+34.04%
|
-
|
|
Jul 12
2022
|
Ian B. Walters Director |
BUY
Grant, award, or other acquisition
|
Direct |
41,666
+34.04%
|
-
|
|
Jul 12
2022
|
Bradley Louis Radoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
41,666
+0.97%
|
-
|
|
Jul 12
2022
|
Bradley Louis Radoff Director |
BUY
Open market or private purchase
|
Direct |
12,500
+0.3%
|
$25,000
$2.27 P/Share
|
|
Jul 05
2022
|
Bradley Louis Radoff Director |
BUY
Open market or private purchase
|
Direct |
120,000
+2.79%
|
$240,000
$2.2 P/Share
|
|
Jun 16
2022
|
Bradley Louis Radoff Director |
BUY
Open market or private purchase
|
Direct |
75,000
+1.81%
|
$150,000
$2.2 P/Share
|
|
Jun 15
2022
|
Hamid Erfanian Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,600
+1.65%
|
$9,200
$2.19 P/Share
|
|
Jun 15
2022
|
Bradley Louis Radoff Director |
BUY
Open market or private purchase
|
Direct |
50,000
+1.24%
|
$100,000
$2.21 P/Share
|
|
Jun 14
2022
|
David Bench Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
3,500
+36.84%
|
$7,000
$2.15 P/Share
|
|
Apr 27
2022
|
Ian B. Walters Director |
BUY
Grant, award, or other acquisition
|
Direct |
39,063
+50.0%
|
-
|
|
Apr 27
2022
|
Bradley Louis Radoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
39,063
+0.98%
|
-
|
|
Apr 27
2022
|
Mary Tagliaferri Director |
BUY
Grant, award, or other acquisition
|
Direct |
39,063
+50.0%
|
-
|
|
Apr 14
2022
|
Bradley Louis Radoff Director |
BUY
Grant, award, or other acquisition
|
Indirect |
30,000
+6.52%
|
$60,000
$2.91 P/Share
|
|
Apr 14
2022
|
David Bench Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
1,620
+39.32%
|
$3,240
$2.9 P/Share
|
|
Apr 13
2022
|
Hamid Erfanian Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+3.57%
|
$20,000
$2.9 P/Share
|
|
Apr 13
2022
|
David Bench Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
880
+50.0%
|
$1,760
$2.9 P/Share
|
|
Nov 08
2021
|
Hamid Erfanian Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
260,000
+50.0%
|
-
|
|
Mar 16
2021
|
Harbert Management Corp > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
300,000
-2.77%
|
$1,200,000
$4.62 P/Share
|
|
Mar 15
2021
|
Harbert Management Corp > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
44,768
-0.81%
|
$223,840
$5.0 P/Share
|